Professor Arri Coomarasamy

Professor Arri Coomarasamy is the Director of Tommy’s National Centre for Miscarriage Research and an NIHR Senior Investigator, with specialist teams in Birmingham, Coventry and London, putting patient priorities at the heart of efforts to tackle the widespread and devastating condition of early pregnancy loss. He also leads researchers at the forefront of reproductive medicine and international efforts to reduce maternal mortality. His portfolio includes numerous national and international multicentre randomised controlled trials, including EMOTIVE (Early detection and treatment of post-partum hemorrhage using the MOTIVE bundle: a World Health Organization cluster randomized trial with health economic analysis), the PROMISE trial (the role of progesterone in women with unexplained recurrent miscarriages), the TABLET trial (levothyroxine therapy for women with thyroid antibodies), the PRISM trial (progesterone therapy for women with early pregnancy bleeding), the RESPONSE trial (G-CSF treatment for recurrent miscarriage), the AIMS trial (the effects of prophylactic antibiotics before miscarriage surgery in low-income countries), the WHO CHAMPION trial (the role of carbetocin to prevent postpartum haemorrhage), the MifeMiso trial (mifepristone plus misoprostol for the management of missed miscarriage) and LOCI (A 2×2 factorial design trial of letrozole versus clomiphene and metformin versus placebo for ovulation induction in women with polycystic ovary syndrome). Consequently he was recently recognised as the “Investigator of the Year” among the NIHR Clinical Research Network for the West Midlands. Professor Coomarasamy has published over 200 medical articles in high impact journals such as NEJM and the Lancet. He serves or has in the past served on several national and international committees including RCOG clinical studies groups in Early Pregnancy and Reproductive Medicine, the BJOG editorial board, the grant review board of the Joint Global Health Trials Initiative from the Wellcome Trust, DfID, MRC and NIHR, and various committees of the World Health Organisation. He is also a Specialist Advisor of the NICE Interventional Procedures Programme, and the founding trustee of Ammalife, a UK-registered charity and leading source of evidence for what works to make childbirth safer in low income countries.